Lim Kok Haw Jonathan, Potts Jonathan R, Chetwood John, Goubet Stephanie, Verma Sumita
Department of Gastroenterology & Hepatology, Brighton & Sussex University Hospitals NHS Trust, Brighton, United Kingdom.
J Dig Dis. 2015 Apr;16(4):228-40. doi: 10.1111/1751-2980.12228.
To assess the determinants of long-term outcome in patients with spontaneous bacterial peritonitis (SBP).
This study was conducted retrospectively. Kaplan-Meier (KM) and Cox proportional hazards survival analyses were performed.
Altogether, 93 patients with SBP were identified, with their mean age of 57.9 ± 12.9 years, Child-Pugh score 10.4 ± 1.9 and model for end-stage liver disease (MELD) score 20.2 ± 6.8. The etiology of chronic liver disease (CLD) was alcohol-related liver disease (ARLD) (n = 58) and viral hepatitis/non-alcoholic steatohepatitis (n = 28). SBP was the index presentation of cirrhosis in 26 (28.0%) patients. Overall mortality was 80.6%; among them 81.3% were liver-related, and 33 (35.5%) died during index hospitalization. In total, 70.0% of patients who survived index hospitalization died during follow-up, with a median survival of 12.5 months. Estimated survival at 3 months, 1 year and 5 years was 54.8%, 34.4% and 15.2%, respectively. Non-ARLD etiology for CLD was an independent predictor of overall mortality (HR 3.484, 95% CI 1.802-6.757, P < 0.001) and mortality in those surviving hospitalization (HR 2.319, 95% CI 1.210-4.444, P = 0.011). Hepatorenal syndrome did not predict outcomes. Two (3.3%) patients surviving hospitalization underwent liver transplantation (LT).
One-year survival after hospitalization with SBP remains poor (34.4%) with unacceptably low LT rates. Non-ARLD etiology for CLD is an independent predictor of both overall mortality and mortality after discharge. In view of the projected increase in non-alcoholic steatohepatitis-related CLD, screening strategies for timely CLD diagnosis are warranted.
评估自发性细菌性腹膜炎(SBP)患者的长期预后决定因素。
本研究为回顾性研究。进行了Kaplan-Meier(KM)和Cox比例风险生存分析。
共纳入93例SBP患者,平均年龄57.9±12.9岁,Child-Pugh评分10.4±1.9,终末期肝病模型(MELD)评分20.2±6.8。慢性肝病(CLD)的病因是酒精性肝病(ARLD)(n = 58)和病毒性肝炎/非酒精性脂肪性肝炎(n = 28)。26例(28.0%)患者的SBP为肝硬化的首发表现。总体死亡率为80.6%;其中81.3%与肝脏相关,33例(35.5%)在首次住院期间死亡。总计,70.0%存活首次住院的患者在随访期间死亡,中位生存期为12.5个月。3个月、1年和5年的估计生存率分别为54.8%、34.4%和15.2%。CLD的非ARLD病因是总体死亡率(HR 3.484,95%CI 1.802 - 6.757,P < 0. 001)和存活住院患者死亡率(HR 2.319,95%CI 1.210 - 4.444,P = 0.011)的独立预测因素。肝肾综合征不能预测预后。2例(3.3%)存活住院的患者接受了肝移植(LT)。
SBP住院后1年生存率仍然很低(34.4%),肝移植率低得令人无法接受。CLD的非ARLD病因是总体死亡率和出院后死亡率的独立预测因素。鉴于非酒精性脂肪性肝炎相关CLD预计会增加,有必要采取筛查策略以便及时诊断CLD。